← Leaderboards
Kiran N Mahajan
University Of North Carolina Chapel Hill
$1,329,949
Attributed
$2,517,850
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$2,517,850 · 3
By mechanism
R01$2,375,802 · 2
F32$142,048 · 1
Top collaborators
- Nupam P Mahajan4 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Rudolph Juliano$14,527,279
- Wenbin Lin$10,248,495
- James L Mohler$8,721,215
- R L Juliano$0
- Gunnar Boysen$1,168,813
Others in their field
Top investigators on “Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$257,543,614
- Charles A Coltman · Southwest Oncology Group$181,133,593
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Larry Arthur$62,719,328
- William J. Blot · Vanderbilt University$62,640,427
- Walter John Curran · Thomas Jefferson University$60,981,384
Research focus
ProstateResistance DevelopmentOrganPhosphotransferasesRecurrenceResistanceCancer PatientNovel TherapeuticsPharmaceutical PreparationsPharmacologicMalignant Neoplasm Of ProstateProstatic NeoplasmsImmune ResponseInhibitorAntagonistAck1 GeneGenerationsModalityAbirateroneEnzalutamideAndrogen Independent Prostate CancerEpigenetic ProcessAndrogen ReceptorSmall Molecule Inhibitor
Grant awards (7)
Phase 1 First in Human Trial to Assess Safety and Tolerability of the Novel ACK1 Inhibitor (R)-9b in Patients with Prostate Cancer$643,764
R01 · FY2025 · CA
Regulation of Androgen Receptor by NXTAR Long non-coding RNA in Prostate Cancer and its Therapeutic Implications$530,267
R01 · FY2025 · CA
Phase 1 First in Human Trial to Assess Safety and Tolerability of the Novel ACK1 Inhibitor (R)-9b in Patients with Prostate Cancer$652,414
R01 · FY2024 · CA
Regulation of Androgen Receptor by NXTAR Long non-coding RNA in Prostate Cancer and its Therapeutic Implications$549,357
R01 · FY2024 · CA
Role of DNA polymerase Mu in lymphomagenesis$51,904
F32 · FY2003 · CA
Role of DNA polymerase Mu in lymphomagenesis$48,148
F32 · FY2002 · CA
Role of DNA polymerase Mu in lymphomagenesis$41,996
F32 · FY2001 · CA